Florida Cancer Specialists & Research Institute Welcomes
Board-certified Hematologist & Medical Oncologist Daniel Ezekwudo, MD, PhD To Charlotte County
Lutathera® is a targeted drug therapy approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin. Learn More.
Florida Cancer Specialists & Research Institute associate director Judy Wang, MD, is lead author of a manuscript on oral bacterial therapy to improve immunotherapy outcomes.
FCS Top News Updates
FCS Expands Footprint Into St. Lucie County, Breaks Ground For New Cancer Center in Tradition
Get the facts about grains and their impact on your health. Discover if eating grains can contribute to a healthy lifestyle or if they should be avoided.
You may have heard the terms Mindful Eating or Intuitive Eating floating around in the news or social media. What do these terms mean? Will these practices help you meet your healthy eating goals?
Breast Cancer in the Millennial EraWomen in their 20s and 30s, are receiving cancer diagnoses, and their cancer is often at more advanced stages. Learn More.
FCS Physician Leaders Examine Best Practices To Improve Speed, Efficiency & Reduce Cost In Bringing Anti-cancer Medicines to PatientsFCS physician abstract co-authors examine best practices to improve speed, efficiency & reduce cost in bringing anti-cancer medicines to patients.
FCS Welcomes Daniel Ezekwudo, MD, PhDFlorida Cancer Specialists & Research Institute Welcomes Board-certified Hematologist & Medical Oncologist Daniel Ezekwudo, MD, PhD To Charlotte County
Pluvicto™ Treatment: What You Can ExpectPluvicto is used to treat adults with prostate cancer that has progressed and who have already received other anticancer treatments.
Xofigo® Treatment: What You Can ExpectXofigo is used to treat prostate cancer that no longer responds to hormonal or surgical treatment that lowers testosterone.
Lutathera® Treatment: What You Can ExpectLutathera® is a targeted drug therapy approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin. Learn More.
FCS Expands Specialized Gynecologic Oncology ServicesMarcia Schmidt, MD, gynecologic oncologist joins Florida Cancer Specialists & Research Institute in Palm Beach County.
Judy Wang, MD is Lead Author of Manuscript Detailing Investigational Treatment to Improve Immunotherapy Outcomes for Patients with Advanced CancersFlorida Cancer Specialists & Research Institute associate director Judy Wang, MD, is lead author of a manuscript on oral bacterial therapy to improve immunotherapy outcomes.
